Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Holding GB:CURE?
Track your performance easily
GB:CURE Technical Analysis
Summary of all the Indicators
Summary
Strong Buy
17Bullish
5Neutral
0Bearish
Oscillators
Buy
5Bullish
5Neutral
0Bearish
Moving Averages
Strong Buy
12Bullish
0Neutral
0Bearish
VanEck Genomics and Healthcare Innovators UCITS ETF Accum A USD’s (CURE) Moving Averages Convergence Divergence (MACD) indicator is -0.18, suggesting VanEck Genomics and Healthcare Innovators UCITS ETF Accum A USD is a Buy.
VanEck Genomics and Healthcare Innovators UCITS ETF Accum A USD’s (CURE) 20-Day exponential moving average is 19.35, making it a Buy.
VanEck Genomics and Healthcare Innovators UCITS ETF Accum A USD’s (CURE) 50-Day exponential moving average is 19.53, making it a Buy.
VanEck Genomics and Healthcare Innovators UCITS ETF Accum A USD (CURE) Pivot Points
Classic
19.05
19.00
19.05
19.00
19.05
19.00
19.05
Fibonacci
19.00
19.00
19.00
19.00
19.00
19.00
19.00
VanEck Genomics and Healthcare Innovators UCITS ETF Accum A USD (CURE) Moving Averages
MA5
19.01Buy
19.21Buy
MA10
19.16Buy
19.21Buy
MA20
19.41Buy
19.35Buy
MA50
19.70Buy
19.53Buy
MA100
19.60Buy
19.53Buy
MA200
19.40Buy
19.44Buy
VanEck Genomics and Healthcare Innovators UCITS ETF Accum A USD’s (CURE) 10-Day exponential moving average is 19.21, making it a Buy.
VanEck Genomics and Healthcare Innovators UCITS ETF Accum A USD’s (CURE) 100-Day exponential moving average is 19.53, making it a Buy.
VanEck Genomics and Healthcare Innovators UCITS ETF Accum A USD’s (CURE) 50-day simple moving average is 19.70, creating a Buy signal.
VanEck Genomics and Healthcare Innovators UCITS ETF Accum A USD’s (CURE) 100-day simple moving average is 19.60, creating a Buy signal.
VanEck Genomics and Healthcare Innovators UCITS ETF Accum A USD’s (CURE) 200-day simple moving average is 19.40, creating a Buy signal.
VanEck Genomics and Healthcare Innovators UCITS ETF Accum A USD (CURE) Technical Analysis
RSI (14)
54.66
Neutral
STOCH (9,6)
47.12
Neutral
STOCHRSI (14)
40.38
Neutral
MACD (12,26)
-0.18
Buy
ADX (14)
14.82
Buy
Williams %R
-29.46
Buy
CCI (14)
51.00
Neutral
ATR (14)
0.24
-
Ultimate Oscillator
56.71
Neutral
ROC
0.41
Buy
VanEck Genomics and Healthcare Innovators UCITS ETF Accum A USD’s (CURE) Relative Strength Index (RSI) is 54.66, creating a Neutral signal.
VanEck Genomics and Healthcare Innovators UCITS ETF Accum A USD’s (CURE) Trend Strength Indicator (ADX) is 14.82, creating a Buy signal.
VanEck Genomics and Healthcare Innovators UCITS ETF Accum A USD’s (CURE) Commodity Channel Index (CCI) is 51.00, creating a Neutral signal.
VanEck Genomics and Healthcare Innovators UCITS ETF Accum A USD’s (CURE) Price Rate of Change (ROC) is 0.41, creating a Buy signal.
FAQ
Is CURE a Buy, Hold, or Sell?
Based on CURE’s technical indicators, CURE is a Strong Buy.
What is CURE’s RSI (14)?
CURE’s RSI (14) is 54.66, which suggests CURE is a Neutral.
What is CURE’s MACD?
CURE’s MACD is -0.18, which suggests CURE is a Buy.
What is CURE’s 5-day moving average?
CURE’s 5-day moving average is 19.01, which suggests CURE is a Buy.
What is CURE’s 20-day moving average?
CURE 20-day moving average is 19.41, which suggests CURE is a Buy.
What is CURE’s 50-day moving average?
CURE’s 50-day moving average is 19.70, which suggests CURE is a Buy.
What is CURE’s 200-day moving average?
CURE’s 200-day moving average is 19.40, which suggests CURE is a Buy.
What is CURE’s Williams % R (14)?
CURE’s Williams % R (14) is -29.46, which suggests CURE is a Buy.
What is CURE’s CCI (14)?
CURE’s CCI (14) is 51.00, which suggests CURE is a Neutral.